Yale Jen
Stock Analyst at Laidlaw & Co.
(0.10)
# 4,516
Out of 5,138 analysts
15
Total ratings
6.67%
Success rate
-15.51%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $16.93 | +254.48% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.64 | +911.99% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $7.10 | +209.86% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.06 | +371.70% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $41.95 | +150.30% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.53 | +122.74% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.72 | +1,284.08% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $116.80 | -58.90% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $2.61 | +18,099.23% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.32 | +9,598.28% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.44 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.38 | +2,521.92% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.81 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $16.93
Upside: +254.48%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.64
Upside: +911.99%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $7.10
Upside: +209.86%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $41.95
Upside: +150.30%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.53
Upside: +122.74%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.72
Upside: +1,284.08%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $116.80
Upside: -58.90%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $2.61
Upside: +18,099.23%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.32
Upside: +9,598.28%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $5.44
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.38
Upside: +2,521.92%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.81
Upside: -